Half-year report · Q2

Period2024-01-01 → 2024-06-30
Filed2024-08-13
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥264m2024-01-01 → 2024-06-30StandaloneNet sales
Revenue¥682m2023-01-01 → 2023-12-31StandaloneNet sales (5-year summary)
Revenue¥359m2023-01-01 → 2023-06-30StandaloneNet sales
Operating income−¥581m2024-01-01 → 2024-06-30StandaloneOperating income
Operating income−¥659m2023-01-01 → 2023-06-30StandaloneOperating income
Ordinary income−¥563m2024-01-01 → 2024-06-30StandaloneOrdinary income
Ordinary income−¥1.2bn2023-01-01 → 2023-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥662m2023-01-01 → 2023-06-30StandaloneOrdinary income
Profit before tax−¥562m2024-01-01 → 2024-06-30StandaloneIncome before income taxes
Profit before tax−¥661m2023-01-01 → 2023-06-30StandaloneIncome before income taxes
Net income−¥564m2024-01-01 → 2024-06-30StandaloneProfit loss
Net income−¥1.2bn2023-01-01 → 2023-12-31StandaloneNet income loss (5-year summary)
Net income−¥664m2023-01-01 → 2023-06-30StandaloneProfit loss
Total assets¥1.6bnat 2024-06-30StandaloneAssets
Total assets¥1.8bnat 2023-12-31StandaloneAssets
Total assets¥1.7bnat 2023-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥487mat 2024-06-30StandaloneLiabilities
Total liabilities¥594mat 2023-12-31StandaloneLiabilities
Net assets / equity¥1.1bnat 2024-06-30StandaloneNet assets
Net assets / equity¥1.2bnat 2023-12-31StandaloneNet assets
Net assets / equity¥1.1bnat 2023-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.1bnat 2024-06-30StandaloneCash and deposits
Cash and deposits¥1.3bnat 2023-12-31StandaloneCash and deposits
Cash & equivalents¥1.1bnat 2024-06-30StandaloneCash and cash equivalents
Cash & equivalents¥1.3bnat 2023-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.2bnat 2023-06-30StandaloneCash and cash equivalents
Cash & equivalents¥1.7bnat 2022-12-31dStandaloneCash and cash equivalents
Operating cash flow−¥677m2024-01-01 → 2024-06-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.1bn2023-01-01 → 2023-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥595m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in operating activities
Investing cash flow¥173,0002023-01-01 → 2023-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥82,0002023-01-01 → 2023-06-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥455m2024-01-01 → 2024-06-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥667m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥113m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-10.212024-01-01 → 2024-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-24.622023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-13.72023-01-01 → 2023-06-30StandaloneBasic earnings loss per share (5-year summary)
Equity ratio68.0%at 2024-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio65.1%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio67.2%at 2023-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued56,387,000at 2024-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued52,640,200at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued48,503,800at 2023-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 16
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30−¥269m
jpcrp040300-q2r_E26096-000Drug Discovery And Developmentreportable segmentsegment profit2024-01-01 → 2024-06-30−¥447m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue2024-01-01 → 2024-06-30¥264m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue external2024-01-01 → 2024-06-30¥264m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentsegment profit2024-01-01 → 2024-06-30¥135m
Total Of Reportable Segments And Otherssegment totalrevenue2024-01-01 → 2024-06-30¥264m
Total Of Reportable Segments And Otherssegment totalrevenue external2024-01-01 → 2024-06-30¥264m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-01-01 → 2024-06-30−¥312m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-06-30−¥266m
jpcrp040300-q2r_E26096-000Drug Discovery And Developmentreportable segmentsegment profit2023-01-01 → 2023-06-30−¥602m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue2023-01-01 → 2023-06-30¥359m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue external2023-01-01 → 2023-06-30¥359m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentsegment profit2023-01-01 → 2023-06-30¥209m
Total Of Reportable Segments And Otherssegment totalrevenue2023-01-01 → 2023-06-30¥359m
Total Of Reportable Segments And Otherssegment totalrevenue external2023-01-01 → 2023-06-30¥359m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-01-01 → 2023-06-30−¥393m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 447
ItemContextValueUnit
Cash and cash equivalents (5-year summary)Prior1QuarterInstant_NonConsolidatedMember1245431000JPY
Cash and cash equivalents (5-year summary)CurrentQuarterInstant_NonConsolidatedMember1103656000JPY
Cash and cash equivalents (5-year summary)Prior1YearInstant_NonConsolidatedMember1325554000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember56387000
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember57049800
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant56387000
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant57049800
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember1450000
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.0257
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember1003500
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.0177
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember998800
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0177
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember962700
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0170
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember830500
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0147
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember700900
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0124
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember700000
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0124
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember551700
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0097
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember517000
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0091
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember440000
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0078
Number of shares heldCurrentQuarterInstant8155100
Shareholding ratioCurrentQuarterInstant0.1446
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember6100
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember56370400
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember563704
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember10500
Number of shares issued shares voting rightsCurrentQuarterInstant56387000
Number of voting rights issued shares voting rightsCurrentQuarterInstant563704
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member6100
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member6100
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.000
Number of shares held in own name treasury shares etcCurrentQuarterInstant6100
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant6100
Shareholding ratio treasury shares etcCurrentQuarterInstant0.000
Cash and depositsPrior1YearInstant_NonConsolidatedMember1325554000JPY
Cash and depositsCurrentQuarterInstant_NonConsolidatedMember1103656000JPY
Accounts receivable tradePrior1YearInstant_NonConsolidatedMember83193000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2023-12-31pass
balance sheet identitynon_consolidated 2024-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-06-30pass
statement vs summary · operating cash flownon_consolidated 2023-01-01/2023-06-30pass
statement vs summary · operating cash flownon_consolidated 2024-01-01/2024-06-30pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-06-30pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-06-30pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2024-06-30pass